Spanish Red Biotech Pipeline

Minoryx

MIN-102 (leriglitazone)

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: Friedreich's Ataxia
Phase: 2Phase II, 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical